Navigation Links
Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes
Date:8/26/2014

SAN DIEGO, Aug. 26, 2014 /PRNewswire/ -- Profil Institute for Clinical Research, Inc., an early phase clinical research organization (CRO) focused on diabetes and obesity, announced today a milestone in clinical research for diabetes with the completion of more than 200 phase I – IIa clinical trials encompassing every clinically relevant drug class for the treatment of type 1 and type 2 diabetes.  

"The significance of this vast amount of research is what it represents for the public domain," said Dan Bradbury, former Amylin Pharmaceutical CEO, managing member of BioBrit, LLC, and member of Profil Institute's Board of Directors.  "Science driven results, as well as advances in clinical research methodologies by Profil Institute have contributed substantially to our understanding of new treatment opportunities and of how early phase clinical research in diabetes and obesity can be conducted in the most meaningful and efficient way.  As a result, we've seen significant progress toward better treatments for both type 1 and type 2 diabetes."

"The sense of urgency related to the diabetes epidemic is increasing with the rapid global rise of diabetes," said Dr. Marcus Hompesch, Profil Institute CEO.  "We've contributed important research to many current therapies providing exciting new treatment options for patients, but we have to continue to outpace ourselves to make an impact on diabetes worldwide.  We a have long, yet promising, path of opportunities in metabolic research as we turn our attention to biomarker discovery to predict and support the treatment of cardiometabolic diseases, as well as looking at novel combination therapies using existing drugs.

"More than a decade ago we decided to focus on diabetes, obesity and cardiometabolic clinical research because, as a group of scientists, that was at the center of
'/>"/>

SOURCE Profil Institute for Clinical Research, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
2. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
3. Profil Institute Partners with Florida Hospital to Establish East Coast Center for Clinical Metabolic Research
4. Abaxis Announces the Launch of Kidney Profile Plus Panel
5. NKTR-192, A New Short-Acting Mu-Opioid Analgesic Molecule, Achieves Desired Pharmacokinetic Profile in First Phase 1a Clinical Study
6. Group Florence Nightingale Increases Radiosurgery Profile with Acquisition of Turkeys First Leksell Gamma Knife Perfexion System
7. Varian Medical Systems Selected by Leading Russian Development Foundations to Take Part in High-Profile Supplier Event
8. Medical Devices Research: Country Reports on Market Profile, Competitive Environment and more at RnRMarketResearch.com
9. High Profile HealthCare Companies: Leading Pharma Company Secures New Patents
10. Upsher-Smith Presents Data Supporting Favorable Tolerability And Consistent Pharmacokinetic Profile Of Once-Daily USL255 (Extended-Release Topiramate)
11. Fortune Magazine Profiles ArcView Group, Co-founded by Steve DeAngelo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015 Concord Medical Services Holdings ... leading specialty hospital management solution provider and operator of the ... China , announced today that an Extraordinary General ... 10:00 a.m. ( Beijing time) at CCM,s ... 3rd Ring Road East, Dongcheng District, Beijing, P.R. ...
(Date:5/4/2015)... 2015  Caris Life Sciences®, a leading biotechnology ... medicine, today announced the designation of MedStar Health ... Caris Centers of Excellence for Precision Medicine Network™ ... Maryland and the Washington, ... in oncology research and treatment, with MedStar Georgetown ...
(Date:5/4/2015)... , TX and VANCOUVER , May 4, ... (TSX-V: EPI) announced today that it has received notification from ... the US that the Company,s IND application, filed March 31, ... the FDA of additional chemistry and pharmaceutical data related to ... a Certificate of Analysis on drug product. The ...
Breaking Medicine Technology:Concord Medical Services Announces 2015 Extraordinary General Meeting of Shareholders 2Caris Life Sciences Designates MedStar Health a Caris Center of Excellence 2Caris Life Sciences Designates MedStar Health a Caris Center of Excellence 3ESSA Pharma Inc. Receives FDA Response on IND Application 2ESSA Pharma Inc. Receives FDA Response on IND Application 3ESSA Pharma Inc. Receives FDA Response on IND Application 4
... , HOUSTON, Oct. 5 PAC, a leading global ... process applications, announces the introduction of the ANTEK MultiTek(TM) ... sulfur , nitrogen, and halides. Industries include ... Pharmaceutical, Environmental, and many more. , "MultiTek(TM) is ...
... , SAN DIEGO, Oct. 2 Pharmatek Laboratories, Inc., ... pharmaceutical industry, announced that it is the first CRO ... enhancing the company,s preclinical and early phase clinical GMP ... to move our customers, drug candidates into the clinic ...
Cached Medicine Technology:New ANTEK MultiTek(TM) by PAC Provides Fast, All-in-One Testing for Sulfur, Nitrogen, Halides 2Pharmatek Laboratories Announces Acquisition of the First Xcelodose(R) 600S System on the West Coast 2
(Date:5/4/2015)... Charlottesville, VA (PRWEB) May 04, 2015 Ticket ... tickets at the John Paul Jones Arena in Charlottesville, ... in the history of the music business and this beloved ... down. Paul McCartney, the former member of two legendary groups: ... decades in the music business since 2013 on the “Out ...
(Date:5/4/2015)... SC (PRWEB) May 04, 2015 Ticket Down ... at the Colonial Life Arena in Columbia, South Carolina. ... the continuation of his “Out There” tour which originally kicked ... long tour is North America and the legendary performer recently ... at the Wells Fargo Arena on June 21st, in Charlottesville, ...
(Date:5/4/2015)... May 04, 2015 New findings released ... Tumor Association (ABTA) show that people diagnosed with a ... treatment options, including clinical trials, at the time of ... make difficult decisions about their course of treatment. The ... the first nationwide brain tumor volunteer network, the ABTA ...
(Date:5/4/2015)... Greensboro, NC (PRWEB) May 04, 2015 ... excited to offer this unique program to other leadership ... create valuable ties between CCL and successful practitioners, expanding ... organizations around the globe,” said John R. Ryan, CCL ... consultancy joins the CCL Partner Network , it ...
(Date:5/4/2015)... American Fork, UT (PRWEB) May 04, 2015 ... the surgery (up to $3,000) of one patient receiving care ... corner of Utah. The procedure must be performed by ... customer (willing to pay in full up front and forego ... the U.S. becomes more economically burdensome every year, and it ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:The Center for Creative Leadership Is Partnering with Lead Star to Create the CCL Partner Network 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3
... ... the 62nd Annual Conference of the Society for Human Resources Management (SHRM). During the ... integration to Human Resource and Payroll professionals at Booth #531 , ... Monterey Park, Calif. (Vocus) June 25, ...
... wine, grapes, blueberries, peanuts and other plants stops ... vision researchers at Washington University School of Medicine in ... vision in blinding eye diseases such as diabetic retinopathy ... in Americans over 50. The formation of new ...
... ... first patent pending method that allows for significant risk reduction for index ... the losses significantly limited or capped while reinvesting index gains accrued to ... Effect." Between 95-100% of the principal value is invested and backed by ...
... ... Values While Creating an Engaged Workforce, , ... Charlotte, NC (Vocus) June 24, 2010 -- ... “Managing the Paradox of Employee Alignment and Engagement.” The free hour-long webinar ...
... HealthDay Reporter , THURSDAY, June 24 (HealthDay News) ... the risk of invasive breast cancer by around 30 ... is considering bisphosphonate use for bone, this might be ... clinical oncologist at the Los Angeles Biomedical Research Institute ...
... trial of a novel radioactive compound readily and safely ... volunteers on brain scans and opens the doors to ... their own radioactive compounds. The results, reported by a ... Nuclear Medicine, could lead to better ways to ...
Cached Medicine News:Health News:NOVAtime participates in the Society for Human Resources Management, (SHRM) 62nd Annual Conference in San Diego, California between June 27 and June 29, 2010 2Health News:NOVAtime participates in the Society for Human Resources Management, (SHRM) 62nd Annual Conference in San Diego, California between June 27 and June 29, 2010 3Health News:Ingredient in red wine may prevent some blinding diseases 2Health News:Ingredient in red wine may prevent some blinding diseases 3Health News:Principal Protected Index Investing Provides Innovative Method to Significantly Reduce Stock Market Loss and Risk 2Health News:Principal Protected Index Investing Provides Innovative Method to Significantly Reduce Stock Market Loss and Risk 3Health News:Morehead Presents Webinar on “Managing the Paradox of Employee Alignment and Engagement”, 2Health News:Bone-Building Pills Appear to Lower Invasive Breast Cancer Risk 2Health News:Bone-Building Pills Appear to Lower Invasive Breast Cancer Risk 3Health News:Novel radiotracer shines new light on the brains of Alzheimer's disease patients 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: